New Delhi: Although there are 2.54 lakh of active COVID-19 cases in the country, people are celebrating and praying without social distancing in the new year as they think the vaccine is not far off. However, they should take precautions as the recent new strain of coronavirus, which spread 70 per cent faster, has already reached India from Britain.
The indigenous COVID-19 vaccine, Covisheild, has already been recommended for emergency use and will reach people in a few days, but its side effects have scared people. The DNA report will try to help you overcome this fear.
First of all, you need to understand the meaning of emergency use. The government has the responsibility to deliver safe and appropriate medicines to you, while the Comptroller General of Medicines of India (DCGI) gives the certificate of purity of medicines. The DCGI investigates the claims of pharmaceutical companies and this decision is made after reviewing human trial reports.
The process to make a safe vaccine is long and takes 8-10 years. Before the completion of this process, if the decision is made for its use, then it is called an emergency use authorization.
Coronavirus is a nearly one-year disease and the process to prepare your vaccine has been completed in comparatively less time, while trials and experiments are still ongoing. As we know that it is a contagious and fatal disease, the arrival of a new strain has created a situation in which the emergency use of the vaccine is being allowed. An emergency use is required to verify the high death toll.
This simply means that the vaccine has already been tested and this process will continue despite its production. The vaccine is safe, but its degree of safety will depend on the result of the data.
The double-dose Covishield vaccine is reported to be 69 percent successful, but this is its efficacy, not its effectiveness. Efficacy means that the vaccine was found to have cured 7 out of 10 people during the trial. The more people are cured, the more effective the vaccine will be. The trial is carried out on healthy people, but it will be given to millions of people to determine its true effectiveness.
The government has made all the preparations for vaccination, but the real challenge lies in removing fear from people’s minds. A survey of 11,000 people in the country has revealed some alarming facts.
The good news is that 5 out of 10 people want to receive this vaccine and are waiting. Four out of 10 people fear this vaccine and, before vaccination, they want to have all the updates.
There are other people who are completely suspicious of the vaccine and do not want to have this vaccine. One in 10 people does not want this vaccine. Compared to young people, older people are more afraid and six out of 10 are not in favor of this vaccine. This report will try to help you overcome your fear by answering some of the most common questions.
How safe is this vaccine?
The vaccine has been used in thousands of people prior to approval, given only after scientists / experts are sure it is completely safe. So far, it has been tested on more than 30 lakh people around the world, and very few of them have faced problems.
After vaccination, people will be observed for 30 minutes in India. If someone has a problem, they will be dealt with immediately, but the chances are slim.
People are curious to know if they will be safe after the first dose of vaccination.
People should know that they will have to take two doses of the vaccine and that their body will be immune to the coronavirus 14 days after the second dose. Even after vaccination, you will have to wear a mask, follow social distancing, and use hand sanitizer.
How long will this vaccine protect us from coronavirus infection?
According to the research carried out so far, the effect of the vaccine will last for six months. However, scientists are of the opinion that this vaccine will strengthen our immunity for many years. More research is needed to reach a conclusion.
It should be noted that the government has decided to send this vaccine to the states through the air route. From the airport, it will be transferred through a refrigerated vehicle to cold rooms, where the vaccines will be stored in coolers and then transported to health centers.
In the health centers, the vaccines will be stored at a temperature of 2 degrees to 8 degrees Celsius, and then they will be transported to the vaccination camps in small refrigerators. All this process will be monitored through GPS.
In the first phase, doctors, nurses and other health workers will be vaccinated. The second phase will include police personnel, journalists, health workers and people over 50 years of age, while patients under 50 will be vaccinated in the third phase.
.
